Composition
- Active ingredients
- LOTEPREDNOL ETABONATE 0.25%
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA210933.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Eysuvis
- Active substance
- loteprednol etabonate
- Route
- Eye
- Dosage form
- Suspension/drops
- Applicant
- Alcon Labs Inc
- Status
- Prescription
- FDA approval
- 26 Oct 2020
- Application
- NDA210933-001